Table 1.
Baseline characteristics by the treatment group
| Variables | Control group (n = 13) | Treatment group (n = 16) | P-value |
|---|---|---|---|
| Age, mean ± standard deviation | 79.3 ± 6.5 | 80.5 ± 8.6 | 0.6850 |
| Male, n (%) | 8 (61.5) | 9 (56.3) | 0.7737 |
| Education, mean ± standard deviation | 14.1 ± 5.2 | 15.7 ± 4.1 | 0.3596 |
| ADAS-cog, mean ± standard deviation | 29.2 ± 8.9 | 26.4 ± 11.9 | 0.4901 |
| ADCS-ADL, mean ± standard deviation | 46.6 ± 7.6 | 49.1 ± 10.3 | 0.4805 |
| MMSE, mean ± standard deviation | 19.4 ± 3.8 | 18.1 ± 4.9 | 0.7239 |
| NPI, mean ± standard deviation | 7.9 ± 11.8 | 5.4 ± 5.9 | 0.4975 |
Abbreviations: ADAS-cog, Alzheimer's Disease Assessment Scale–cognitive subscale; MMSE, Mini–Mental State Examination; ADCS-ADL, Alzheimer's Disease Cooperative Study–Activities of Daily Living Scale; NPI, Neuropsychiatric Inventory.